Pharmacokinetics of Tapentadol in Subjects With Varying Degrees of Renal Impairment

被引:0
|
作者
Smit, J. W. [1 ]
Kleideiter, E. [2 ]
Brett, M. [3 ]
Lannie, C. [1 ]
Mangold, B. [1 ]
机构
[1] Johnson & Johnson Phamaceut Res & Dev, Div Janssen Phamaceut, Beerse, NV, Belgium
[2] Grunenthal GmbH, Global Clin Dev, Aachen, Germany
[3] Grunenthal GmbH, Global Preclin Dev, Aachen, Germany
来源
JOURNAL OF CLINICAL PHARMACOLOGY | 2010年 / 50卷 / 09期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
95
引用
收藏
页码:1079 / 1079
页数:1
相关论文
共 50 条
  • [21] Effect of Varying Degrees of Renal Impairment on the Pharmacokinetics of Omecamtiv Mecarbil
    Ashit Trivedi
    Rajneet K. Oberoi
    Pegah Jafarinasabian
    Hanze Zhang
    Stephen Flach
    Siddique Abbasi
    Sandeep Dutta
    Edward Lee
    [J]. Clinical Pharmacokinetics, 2021, 60 : 1041 - 1048
  • [22] Effect of Varying Degrees of Renal Impairment on the Pharmacokinetics of Omecamtiv Mecarbil
    Trivedi, Ashit
    Oberoi, Rajneet K.
    Jafarinasabian, Pegah
    Zhang, Hanze
    Flach, Stephen
    Abbasi, Siddique
    Dutta, Sandeep
    Lee, Edward
    [J]. CLINICAL PHARMACOKINETICS, 2021, 60 (08) : 1041 - 1048
  • [23] Effect of varying degrees of renal impairment on the pharmacokinetics and tolerability of taspoglutide
    Giraudon, Mylene
    Sturm, Stefan
    Lambert, Nathalie
    Niggli, Markus
    Brumm, Jochen
    Mangold, Bernhard
    Schmitt, Christophe
    [J]. DIABETES OBESITY & METABOLISM, 2017, 19 (04): : 537 - 544
  • [24] PHARMACOKINETICS OF TEICOPLANIN IN SUBJECTS WITH VARYING DEGREES OF RENAL-FUNCTION
    DERBYSHIRE, N
    WEBB, DB
    ROBERTS, D
    GLEW, D
    WILLIAMS, JD
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 23 (06) : 869 - 876
  • [25] Pharmacokinetics (PK) of palifermin in subjects with different degrees of renal impairment
    Gillespie, B
    Zia-Amirhosseini, P
    Salfi, M
    Wang, J
    Robson, R
    Sullivan, JT
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (09): : 1071 - 1071
  • [26] A Pharmacokinetic Study of Plerixafor in Subjects with Varying Degrees of Renal Impairment
    MacFarland, Ronald
    Hard, Marjie L.
    Scarborough, Robert
    Badel, Karin
    Calandra, Gary
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (01) : 95 - 101
  • [27] Pharmacokinetics (PK) of posaconazole in subjects with varying degrees of renal insufficiency.
    Courtney, R
    Sansone, A
    Statkevich, P
    Martinho, M
    Richards, W
    Laughlin, M
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P45 - P45
  • [28] Pharmacokinetics of linezolid in subjects with varying degrees of renal function and on dialysis.
    Brier, ME
    Stalker, DJ
    Aronoff, GR
    Batts, DH
    Ryan, KK
    O'Grady, MA
    Hopkins, NK
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (07) : 276A - 276A
  • [29] Regadenoson's pharmacokinetics in subjects with varying degrees of renal function.
    Gordi, T
    Lee, S
    Belardinelli, L
    Lieu, H
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P51 - P51
  • [30] Single-dose pharmacokinetics of ibrutinib in subjects with varying degrees of hepatic impairment
    de Jonga, Jan
    Skee, Donna
    Hellemans, Peter
    Jiao, James
    de Vries, Ronald
    Swerts, Dominique
    Lawitz, Eric
    Marbury, Thomas
    Smith, William
    Sukbuntherng, Juthamas
    Mannaert, Erik
    [J]. LEUKEMIA & LYMPHOMA, 2017, 58 (01) : 185 - 194